Cited by 285Schizophrenia research and treatmentAntioxidant Activity and Oxidative StressTryptophan and brain disorders

The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

Open access

Yao, Jeffrey K., Keshavan, Matcheri S.·2011·Antioxidants & Redox Signaling

DOI 10.1089/ars.2010.3603PMC PMC3159108

Open this paper in CoChat — free account

Abstract

Schizophrenia (SZ) is a brain disorder that has been intensively studied for over a century; yet, its etiology and multifactorial pathophysiology remain a puzzle. However, significant advances have been made in identifying numerous abnormalities in key biochemical systems. One among these is the antioxidant defense system (AODS) and redox signaling. This review summarizes the findings to date in human studies. The evidence can be broadly clustered into three major themes: perturbations in AODS, relationships between AODS alterations and other systems ( i.e. , membrane structure, immune function, and neurotransmission), and clinical implications. These domains of AODS have been examined in samples from both the central nervous system and peripheral tissues. Findings in patients with SZ include decreased nonenzymatic antioxidants, increased lipid peroxides and nitric oxides, and homeostatic imbalance of purine catabolism. Reductions of plasma antioxidant capacity are seen in patients with chronic illness as well as early in the course of SZ. Notably, these data indicate that many AODS alterations are independent of treatment effects. Moreover, there is burgeoning evidence indicating a link among oxidative stress, membrane defects, immune dysfunction, and multineurotransmitter pathologies in SZ. Finally, the body of evidence reviewed herein provides a theoretical rationale for the development of novel treatment approaches. Antioxid. Redox Signal. 15, 2011–2035.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1089/ars.2010.3603

Cites

296 of 296 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,786
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
Janero, D. R. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90131-2 · Cited by 2,735
Psychiatric disorders in America: the epidemiologic catchment area study
(1991) · Choice Reviews Online · doi:10.5860/choice.28-5931 · Cited by 2,561
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055
Schizophrenia
van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971

Show all 296 references

Research works printed but not linked: 18

Bartosz G. Commentary on: free radicals and the developmental pathology of schizophrenic burnout. Integr Psychiatry, 5:43–44. 1987.
Cadet JL, , Lohr JB. Free radicals and the developmental pathology of schizophrenic burnout. Integr Psychiatry, 5:40–48. 1987.
Frankel EN. Lipid oxidation. Dundee, Scotland: The Oily Press Ltd., 1998.
10.1177/153537029922200312 · DOI
Halliwell B, , Gutteridge JMC. Oxygen radicals and the central nervous system. TINS, 8:22–26. 1984.
Horrobin DF. Niacin flushing, prostaglandin E and evening primrose oil: a possible objective test for monitoring therapy in schizophrenia. J Orthomo Psychiatr, 9:33–34. 1980.
Javitt DC, , Laruelle M. Neurochemical theories. Text Book of Schizophrenia. Lieberman JA, , Stroup TS, , Perkins DO. Washington, DC: The American Psychiatric Publishing, 2006; 85–116.
Keshaven MS, , Pettegrew JW, , Ward R. Are membrane phospholipid changes in schizophrenia familial? Biol Psychiatry, 33:45A. 1993.
Mahadik SP, , Yao JK. Phospholipids in schizophrenia. Textbook of Schizophrenia. Lieberman JA, , Stroup TS, , Perkins DO. Washington, DC: The American Psychiatric Publishing, Inc., 2006; 117–135.
Mahadik SP, , Parikh V, , Khan MM. The role of oxidative stress in modulating membrane and phospholipid function in schizophrenia. Phospholipid Spectrum Disorders in Psychiatry and Neurology. Peet M, , Glen I, , Horrobin D. Carnforth, UK: Marius Press, 2003; 277–288.
Pillai A, , Reddy R, , Yao JK. Oxidative stress in schizophrenia. Fatty Acids and Oxidative Stress in Neuropsychiatric Disorders. Reddy R, , Yao JK. New York: Nova Biochemical Books, 2007; 29–42.
Pryor WA, , Stone K. Oxidants in cigarette smoke. Ann N Y Acad Sci, 686:29. 1992.
Sinet PM, , Debray Q, , Carmagnol F, , Pelicier Y, , Nicole A, , Jerome H. Normal erythrocyte SOD values in two human diseases: schizophrenia and cystic fibrosis. Oxy Radicals and Their Scavenger Systems, Cellular and Medical Aspects, II Greenwald RA, , Cohen G. New York: Elsevier, 1983; 302–304.
Suzuki K. Chemistry and metabolism of brain lipids. Basic Neurochemistry, 3rd Siegel GJ, , Albers RW, , Agranoff BW, , Katzman R. Boston, MA: Little, Brown & Co., 1981; 355–370.
10.1016/S1570-0232(04)00595-1 · DOI
Yao JK, , van Kammen DP, , Reddy RD, , Kelley ME. Superoxide dismutase and negative symptoms in schizophrenia. Biol Psychiatry, 43:123S–124S. 1998. · DOI
Yao JK. Abnormalities of fatty acid metabolism in red cells, platelets and brain in schizophrenia. Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd Peet M, , Glen I, , Horrobin DF. Lancashire, UK: Marius Press, 2003; 193–212.
Zhang ZJ, , Ramchand CN, , Ramchand R, , Milner E, , Telang SD, , Peet M. Glutathione peroxidase (GSHPx) activity in plasma and fibroblasts from schizophrenics and control. Biol Psychiatry, 29:103–104. 1998.

Sorted by citations

Items 201–284 of 284

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
Gao, Z., Xiu, M., Liu, J., Wu, F., & Zhang, X. (2023) · Schizophrenia · doi:10.1038/s41537-023-00346-z · Cited by 7
Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia
Guan, X., Chen, Y., Wang, X., Xiu, M., Wu, F., & Zhang, X. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.12.004 · Cited by 8
Electrochemistry as a Tool for Redox‐Based Bio‐Information Processing
Kim, E., Chen, C., Zakaria, F. R., Motabar, D., Kang, M., Kelly, D. L., Napolitano, A., Bentley, W. E., & Payne, G. F. (2025) · Advanced Science · doi:10.1002/advs.202510184 · Cited by 5
Expression Analysis of 4-Hydroxynonenal Modified Proteins in Schizophrenia Brain; Relevance to Involvement in Redox Dysregulation
Manzoor, S., Ayesha, K., Hasan, B., Mushtaq, S., & Ahmed, N. (2021) · Current Proteomics · doi:10.2174/1570164618666210121151004 · Cited by 5
Oxidative Stress in Schizophrenia
Dietrich‐Muszalska, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_2 · Cited by 5
Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia
Wang, X., Xiu, M., Wang, K., Su, X., Li, X., & Wu, F. (2022) · Metabolomics · doi:10.1007/s11306-022-01909-4 · Cited by 5
The activity of erythrocyte and platelet glutathione reductase and glutathione-S-transferase in paranoid schizophrenia
Savushkina, O. K., Бокша, И. С., Prokhorova, T. A., Терешкина, Е. Б., Burminskiy, D. S., Ma, M., Vorobyeva, E. A., & Burbaeva, G. S. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201811811177 · Cited by 5
Hippocampal reelin and GAD67 gene expression and methylation in the GFAP.HMOX1 mouse model of schizophrenia
Tavitian, A., Lax, E., Song, W., Szyf, M., & Schipper, H. M. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119899 · Cited by 4
Combined treatment with pantothenic acid derivatives and memantine alleviates scopolamine-induced amnesia in rats: The involvement of the thiol redox state and coenzyme A
Stepanichev, M. Y., Markov, D. A., Freiman, S. V., Фролова, О. А., Omelyanchik, S. N., Бородина, Т. А., Novikova, M. R., Канунникова, Н. П., Onufriev, M. V., Мойсеенок, А. Г., et al. (2016) · Neurochemical Journal · doi:10.1134/s1819712416020094 · Cited by 4
Ethanolic extract of Erythrina velutina Willd ameliorate schizophrenia-like behavior induced by ketamine in mice
Ximenes, N. C., Júnior, M. A. S., Vasconcelos, G. S., Dias, K. C. F., Jucá, M. M., Silva, A. H., Leal, L. K. A. M., Viana, G. S. D. B., de Sousa, F. C. F., & Vasconcelos, S. M. M. (2018) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2018-0038 · Cited by 4
Different Directions of Effects of Polyclonal IgG Antibodies from Patients with Schizophrenia and Healthy Individuals on Cell Death In Vitro: A Pilot Study
Epimakhova, E. V., Smirnova, L. P., Kazantseva, D. V., Kamaeva, D. A., & Ivanova, S. А. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040206 · Cited by 4
Human blood analysis reveals differences in gene expression of catecholamine-regulated protein 40 (CRP40) in schizophrenia
Groleau, S. E., Lubarda, J., Thomas, N., Ferro, M. A., Pristupa, Z. B., Mishra, R. K., & Gabriele, J. P. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.034 · Cited by 4
Identification of a functional SNP rs7304782 at schizophrenia risk locus 12q24.31 and validation of its association with schiz ophrenia in Chinese populations
Ma, C., Li, Y., Li, X., Liu, J., & Luo, X. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113491 · Cited by 4
Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid
Adrien, V., Bosc, N., Fumat, H., Tessier, C., Ferreri, F., Mouchabac, S., Tareste, D. C., & Nuss, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1089724 · Cited by 4
The Role of Nitric Oxide and Nitrosative Stress in Schizophrenia
Dietrich‐Muszalska, A., Bartosz, G., & Sadowska‐Bartosz, I. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_15 · Cited by 4
Antioxidant Interventions in Neuropsychiatric Disorders
Pillai, A., & Yao, J. K. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_25 · Cited by 4
Self-citation
Mitochondrial Dysfunction in Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit Mouse Model
Monpays, C., Deslauriers, J., Sarret, P., & Grignon, S. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0746-3 · Cited by 5
Toward a Pluralistic Model for the Schizophrenia Spectrum—Dopamine and Beyond
Keshavan, M. S., Nasrallah, H. A., Abi‐Dargham, A., Grace, A. A., Dc, J., Lewis, D. A., Marder, S. R., Meyer, J. M., Murray, R. M., Öngür, D., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.1684 · Cited by 3
Self-citation
A CRITICAL REVIEW ON HYPOTHESIS, PATHOPHYSIOLOGY OF SCHIZOPHRENIA, AND ROLE OF VITAMINS IN ITS MANAGEMENT
Jose, R., Venketeswaramurthy, N., & Sambath Kumar, R. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i8.23259 · Cited by 3
Platelet Enzymes of Glutathione Metabolism in Patients with Late-Onset Schizophrenic Spectrum Disorders
Savushkina, O. K., Бокша, И. С., Терешкина, Е. Б., Prokhorova, T. A., Sheshenin, V., Витальевна, П. В., Vorobyeva, E. A., & Burbaeva, G. S. (2020) · Psikhiatriya · doi:10.30629/2618-6667-2020-18-4-41-50 · Cited by 3
The Gordian knot of the immune-redox systems’ interactions in psychosis
Karanikas, E. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000481 · Cited by 3
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials
Ghaderi, A., Bussu, A., Tsang, C., & Jafarnejad, S. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2595-1 · Cited by 3
Retracted
Coronary artery disease and schizophrenia: the interplay of heart and mind
Protty, M. B. (2019) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcz005 · Cited by 3
Aging in Schizophrenia: Perspectives on Molecular Mechanisms and a Mini-review
Weerasekera, A., Dost, Ö., & Fei, D. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf099 · Cited by 2
Correlation between uric acid/high-density lipoprotein cholesterol ratio and carotid plaque formation: A retrospective cross-sectional study in Anhui's health check-up population
Zhang, X., Liu, T., 雷玉娟, Zhao, Q., 常瑜, & Hu, H. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113153 · Cited by 2
Association between serum uric acid levels and cognitive performance in first-episode drug-naïve schizophrenia: A large cross-sectional study
Zhang, X., Li, X., Zhang, G., Li, C., & Lang, X. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117314 · Cited by 2
Assessment of serum level of total glutathione in a sample of schizophrenic patients versus bipolar patients
Fathy, H., Bayoumy, H. A. H., Mawella, S. M. A., Gomaa, M. A., & Al-Hanafi, H. (2015) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000471347.83522.d8 · Cited by 2
Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
Jiang, Q., Zhang, X., Lu, X., Li, Y., Lu, C., Chi, J., Ma, Y., Shi, X., Wang, L., & Li, S. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s427557 · Cited by 2
Schizophrenia: One Coat of Many Colors
Smythies, J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00043 · Cited by 2
Possible Biomarkers Modulating Haloperidol Efficacy and/or Tolerability
Porcelli, S., Crisafulli, C., Calabrò, M., Serretti, A., & Rujescu, D. (2016) · Pharmacogenomics · doi:10.2217/pgs.16.5 · Cited by 2
Local cytokine status in patients with sialadenosis of parotid glands with hypothyroidism
Сультимова, Т. Б., Козлова, М. В., Михайлович, Г. А., Савлевич, Е. Л., & Kozlov, I. G. (2021) · Immunologiya · doi:10.33029/0206-4952-2021-42-4-356-363 · Cited by 2
Effects and Therapeutic Use of TMS in Psychiatric Disorders: An Evidence-Based Review
Escribano, B. M., Fernández, F. J. M., Caballero‐Villarraso, J., Feijóo, M., Agüera, E., & Túnez, I. (2019) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000560 · Cited by 2
Air Pollution and Neurodevelopmental Disorders
Allen, J. L., Klocke, C. R., Morris‐Schaffer, K., Conrad, K., Sobolewski, M., & Cory‐Slechta, D. A. (2022) · Wiley eBooks · doi:10.1002/9781119316329.ch11 · Cited by 2
Antioxidant Status in Paranoid Schizophrenia and Alzheimer’s Disease
Sokolova, S. V., Sozarukova, M. M., Khannanova, A. N., Grishina, N. K., Portnova, G. V., & Proskurnina, E. V. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01052-y · Cited by 1
Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study
宋修丽, Xiu, M., Yao, J., Wu, F., Zhang, X., & Zhang, X. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231019105328 · Cited by 1
N-acetylcysteine enhances the antipsychotic effect of aripiprazole in the neurodevelopmental rat model of schizophrenia
Rogóż, Z., Kamińska, K., & Wąsik, A. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174028 · Cited by 1
Imaging transcriptomics identifies gene signatures associated with cortical thinning in schizophrenia
Tu, Y., Li, S., Guan, S., Xin, Y., Tao, H., Zhou, Z., Wang, S., Jiang, H., & Xu, H. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.008 · Cited by 1
EFFECT OF GINKGO BILOBA, RISPERIDONE AND BIPERIDEN REGIMEN IN CHRONIC SCHIZOPHRENIA
Nikfarjam, M., Goodarzi, I., Arshad, S., Parvin, N., & Safdari, F. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Oxidative Stress in Schizophrenia: Relation to Neurochemical Pathogenetic Hypotheses
Burbaeva, G. S., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Бокша, И. С. (2024) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-6-85-99 · Cited by 1
The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood
Lorenc‐Koci, E., Górny, M., Chwatko, G., Kamińska, K., Iciek, M., & Rogóż, Z. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00607-3 · Cited by 1
Cigarette Smoking and Increased Susceptibility to Mycobacterium tuberculosis Infection
Brazil, J., & Venketaraman, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-97367-8_6 · Cited by 1
Neurobiological Meaning of Omega-3 Fatty Acids and Their Potential Role in the Treatment of Schizophrenia
Mazza, M., Marano, G., Traversi, G., Mazza, S., & Janiri, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815238-6.00018-3 · Cited by 1
Antioxidant status in patients with paranoid schizophrenia and Alzheimer disease
Sokolova, S. V., Sozarukova, M. M., Khannanova, A. N., Grishina, N. K., Portnova, G. V., & Proskurnina, E. V. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012006182 · Cited by 1
Galantamine as Adjunctive Treatment for Ameliorating Negative Symptoms of Schizophrenia Patients
Roshandel, Z., Norouzi, S., Haghdoost, M. R., & Fakhri, A. (2021) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.114989 · Cited by 1
Lowered Serum Cesium Levels in Schizophrenia: Association with Immune-Inflammatory Biomarkers and Cognitive ImpairmentsPreprint
Almulla, A. F., Moustafa, S. R., Al-Dujaili, A. H., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202002.0175.v1 · Cited by 1
Estrés Oxidativo y Esquizofrenia
Prados, A. B. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124073
Adolescent mental health 1 Changes in the adolescent brain and the pathophysiology of psychotic disorders
Keshavan, M. S., Medical, B. I. D., & Lau, J. Y. F. (2014)
Self-citation
Multilevel Approaches to Schizophrenia and Other Psychotic Disorders: The Biobehavioral Interface
Walker, E. F., Ryan, A. T., Goines, K., Novacek, D. M., Goulding, S. M., Brasfield, J. L., MacDonald, A. N., & Trotman, H. D. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy322
Innate Immune Response and Psychotic Disorders
Suvisaari, J., & Mantere, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801968-9.00007-6
Oxidative and nitrative stress in schizophrenia
Dietrich‐Muszalska, A. (2016) · Wiley eBooks · doi:10.1002/9781118832431.ch5
The Downstream Targets of Complex I Dysfunction in Bipolar Disorder
Kim, H. K. (2015) · TSpace (University of Toronto)
Διερεύνηση της δράσης των παραγώγων του Crocus sativus L. επί του κεντρικού νευρικού συστήματος στον επίμυ
Γεωργιάδου, Γ. (2013) · doi:10.12681/eadd/29425
Proteômica da esquizofrenia: busca por biomarcadores em plaquetas
Joaquim, H. P. G. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-09042018-095856
Pathophysiology of psychotic disorders and the need for novel therapeutic targets
Keshavan, M. S. (2012) · doi:10.2217/ebo.12.9
Self-citation
Parvalbumin阳性中间神经元缺陷在精神分裂症病理机制中的作用
Deng, X., & Guo, J. (2018) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2018.01992
The occurrence of metabolic and inflammatory causes of psychosis in admissions to a psychiatric unit
Fanea, G. (2018) · Research Explorer (The University of Manchester)
Neuroinflammation and Staging
Baune, B. T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139839518.008
Novel Biological Treatment Strategies
Amminger, G. P., & Berger, M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139839518.011
Avaliação do efeito de antipsicóticos em cultura de oligodendrócitos humanos, através de análises de proteoma : Evaluating antipsychotics effects on a human oligodendrocyte culture, through proteome analyses
Seabra, G. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Effects of Antipsychotic Treatment on S100B and Oxidative Stress in Patients with Schizophrenia
Wang, X., Bian, Y., Liu, L., Wu, Y., Yang, F., Li, X., Han, X., Tian, L., Luο, X., Chen, S., et al. (2019) · Global Clinical and Translational Research · doi:10.36316/gcatr.01.0018
Pronounced immunological abnormalities in unmedicated first episode as compared to chronic schizophrenia patients
Milleit, B., Hesse, J., Langbein, K., Rödiger, K., Milleit, C., Meier, U., Elsner, P. U., Hipler, U., & Smesny, S. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.10.002
Recent Developments in Treating Cognitive Impairment Associated with SchizophreniaPreprint
Bittner, R. A., Barnes-Scheufler, C. V., Hettwer, M. D., Reif, A., & Qubad, M. (2021) · Preprints.org · doi:10.20944/preprints202105.0257.v1
COVID-19: A Catalyst for Novel Psychiatric Paradigms - Part 1
Sfera, A., Osorio, C. P., Maldonado, J. E. C., Jafri, A., Chokka, A. D., del Campo, C. M. Z.-M., & Kozlakidis, Z. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96940
The Difference in Negative Scale Score Measured with Positive and Negative Syndrome Scale in Schizophrenic Male Patient Treated with Risperidone in Addition to Vitamin E and Treated with Risperidone Alone at Prof. Dr. M. Ildrem Mental Hospital Medan
Nanda, R., Effendy, E., & Amin, M. M. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6341
PERIPHERAL NON_ ENZYMATIC ANTIOXIDANTS LEVELS IN SCHIZOPHRENIA AND BIPOLAR ILLNESS A COMPARATIVE CROSS-SECTIONAL STUDY
Acharya, R. K., Gupta, R., & Gehlot, S. (2021) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v5i8.2107
The Effect of Glutathione Deficit During Early Postnatal Brain Development on the Prepulse Inhibition and Monoamine Levels in Brain Structures of Adult Sprague–Dawley Rats
Rogóż, Z., Lech, M. A., Chamera, K., & Wąsik, A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00496-5
Effects of GPX3 and GSTA1 Polymorphisms on the Risk of Schizophrenia in Chinese Han PopulationPreprint
Liu, C., Song, S., Zhang, J., Li, X., & Gao, H. (2019) · Research Square · doi:10.21203/rs.2.13319/v1
Faculty Opinions recommendation of Meta-analysis of oxidative stress in schizophrenia.
Altamura, A. C., & Buoli, M. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718074530.793484196
Redox regulation of cobalamin status in human neuronal cells and cerebral cortex
Zhang, Y. (2016) · Digital Repository Service (Northeastern University) · doi:10.17760/d20213496
Interacción calmodulina-melatonina: efectos sobre la oxidación de la calmodulina y la actividad de la calmodulina cinasa II
Argueta, J. (2022) · doi:10.24275/uami.2f75r8323
Differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an MK-801-induced mouse model of schizophrenia
Jiao, S., Li, N., Cao, T., Wang, L., Chen, H., Lin, C., & Cai, H. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111011
RETRACTED: Molecular structure of VEGFA polysaccharide protein and its regulation of monocyte infiltration and oxidative stress after myocardial infarction
Huang, Z., Wen, B., Wang, M., Lu, Y., Ji, Q., Mei, J., Shi, X., & Jiang, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143199
Retracted
Reactive oxygen species and psychiatric disorders
Knežević, N. N., Nenic, K., Knezevic, E., & Janković, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27333-9.00016-6
The Pathobiological Underpinnings of Psychosis: From the Stress-Related Hypothesis to a Multisystemic Approach
Karanikas, E. (2025) · NeuroSci · doi:10.3390/neurosci6040099
Alteration pattern of serum albumin levels in schizophrenia from first episode through remission to relapse: a longitudinal study
Zhao, Y., Luo, H., Gao, S., Tang, Y., Guo, Y., Hao, W., Zhang, R., Zhai, D., & Wen, S. W. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03885-y
Glutathione deficiency in the early postnatal developmental period as a neurodevelopmental animal model of schizophrenia
Rogóż, Z., & Wąsik, A. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00853-7
Disrupted Oxidative-Antioxidant Balance in Schizophrenia: A Case-Control Study Evaluating Serum Malondialdehyde and Plasma Superoxide Dismutase
Ghosh, A. K., Das, N. K., & Bhowmik, K. K. (2026) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20260201
Silent Inflammation: A Critical Narrative Review of the Relationship Between Periodontal Disease and Psychosis—The Role of Oxidative Stress and Iatrogenic Comorbidities
Focseneanu, B. E., Ciobanu, M. R., Pangică, A. M., Ionescu, P. T., Pangica, T. M., Marian, G., & Bîcleşanu, F. C. (2026) · Antioxidants · doi:10.3390/antiox15060679
Association between serum non-enzymatic antioxidants and cognitive impairment in drug-naïve patients with schizophrenia
Feng, Z., Qiu, Y., Wang, Y., Li, M. T., Sun, X., Su, Q., Xuekelaiti, Z., Wang, S. Y., Xu, Y., Zhang, Y., et al. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08177-9
Hydrogen Peroxide Dismutation by Immunoglobulins G from Patients with Schizophrenia
Kazantseva, D. V., Smirnova, L. P., Kornetova, E. G., & Ivanova, S. A. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926600456
Association of oxidative stress, metacognition, and psychopathology in patients with schizophrenia: a case-control study
Hu, X., Cheng, J., Xia, S., La, M., Zhang, Y., Zhang, L., Meng, X., Zhang, X., Wang, D., & Zhang, A. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1899294
From Micro Molecular to Functional Levels Through Macro Structures: Mediation of Structural Brain Changes on the Relationship Between Oxidative Stress and Cognition in Early Onset Psychosis
Villar-Arenzana, M., Taulero-Escalera, B., MacDowell, K. S., Fraguas, D., Bombín, I., Castro‐Fornieles, J., Moreno, C., Baeza, I., Ramirez Serna, E., Pinto, A. G., et al. (2026) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgag030
Senescence-associated secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data
Seitz‐Holland, J., Haaf, M., Mendes‐Silva, A. P., Penzel, N., Berberich, C., Sylvain Bouix, A., Coleman, M. J., Kotler, E., Kim, N., Burdick, K. E., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107023
Self-citation
Molecular Crossroads: Exploring the Role of Oxidative Stress and Glutamate in Schizophrenia - A Pathway to Antioxidant Therapy
Manvini., S., & Verma, P. (2026) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2026.00052

Authors: Yao, J. K., & Keshavan, M. S.
Affiliations: University of Pittsburgh (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Yao, Jeffrey K.
ORCID: Keshavan, Matcheri S.
Venue: Antioxidants & Redox Signaling
Publisher: SAGE Publications
Published: 2011-10
Volume: 15
Issue: 7
Pages: 2011-2035
ISSN: 1523-0864 (ISSN-L)
1557-7716
DOI: 10.1089/ars.2010.3603
PMC: PMC3159108
OpenAlex: W2063765492
Cited by: 285
References: 296
Citations by year: 2026: 14 · 2025: 13 · 2024: 8 · 2023: 10 · 2022: 13 · 2021: 20 · 2020: 17 · 2019: 25 · 2018: 16 · 2017: 27 · 2016: 26 · 2015: 23 · 2014: 25 · 2013: 26 · 2012: 13
FWCI: 2.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Antioxidants and Redox Signaling (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
Office of Research and Development (MH58141)
VA Pittsburgh Healthcare System
National Institute of Mental Health (MH-58141, R01MH045203, MH45203, R01MH058141)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: schizophrenia, antioxidant defense, redox signaling, oxidative stress, lipid peroxidation, nitric oxide, purine catabolism, plasma antioxidant capacity, membrane structure, immune dysfunction, neurotransmission, schizophrenia pathophysiology, novel treatment approaches
MeSH terms: Animals, Antioxidants, Blood Proteins, Cell Membrane, Glutathione, Humans, Inflammation, Synaptic Transmission, Nitric Oxide, Oxidation-Reduction, Schizophrenia, Signal Transduction, Reactive Oxygen Species, Neurotransmitter Agents, Oxidative Stress, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks